These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32296987)

  • 1. Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation.
    Tashan E; Karakucuk A; Celebi N
    AAPS PharmSciTech; 2020 Apr; 21(3):115. PubMed ID: 32296987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
    Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
    Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Karaküçük A; Taşhan E; Öztürk N; Çelebi N
    Turk J Pharm Sci; 2021 Apr; 18(2):223-227. PubMed ID: 33902264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
    Gowda V; Pabari RM; Kelly JG; Ramtoola Z
    Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design.
    Özyılmaz ED; Comoglu T
    Drug Dev Ind Pharm; 2022 Nov; 48(11):667-681. PubMed ID: 36454038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product.
    Chen Y; Feng T; Li Y; Du B; Weng W
    Pharm Dev Technol; 2017 Mar; 22(2):168-172. PubMed ID: 26654222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast and pH-dependent release of domperidone from orally disintegrating tablets.
    Assaf SM; Qandil AM; Al-Ani EA
    Pharm Dev Technol; 2013; 18(4):897-905. PubMed ID: 22304659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
    Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized furosemide taste masked orally disintegrating tablets.
    Ibrahim MA; Abou El Ela AESF
    Saudi Pharm J; 2017 Nov; 25(7):1055-1062. PubMed ID: 29158715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
    Cantor SL; Khan MA; Gupta A
    Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve Paediatric Patient's Compliance.
    Juan C; Gallo L; Gonzalez Vidal N
    AAPS PharmSciTech; 2024 Apr; 25(4):79. PubMed ID: 38589718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.